MKI67 and neoplasm: The biological continuum from polyclonal hyperplasia to monoclonal neoplasia mandates a multidisciplinary approach—integrating serial endoscopic surveillance for subcentimeter lesions, Ki67-indexed risk stratification, and judicious surgical intervention—to optimize the critical transition from oncologic vigilance to therapeutic action while preserving intestinal function.